U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C15H17IN2O2S
Molecular Weight 416.277
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ML-7

SMILES

IC1=CC=CC2=C(C=CC=C12)S(=O)(=O)N3CCCNCC3

InChI

InChIKey=GEHJIACZUFWBTK-UHFFFAOYSA-N
InChI=1S/C15H17IN2O2S/c16-14-6-1-5-13-12(14)4-2-7-15(13)21(19,20)18-10-3-8-17-9-11-18/h1-2,4-7,17H,3,8-11H2

HIDE SMILES / InChI
1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine (ML-7) is an inhibitor of myosin light chain kinase (MLCK). It is widely used to study MLCK signaling both in vitro and in vivo.

CNS Activity

Curator's Comment: ML-7 is CNS active in animals. No human data available.

Originator

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
0.3 µM [Ki]
Conditions
PubMed

PubMed

TitleDatePubMed
Association of aorta intima permeability with myosin light chain kinase expression in hypercholesterolemic rabbits.
2011-01
Murine vasa recta pericyte chloride conductance is controlled by calcium, depolarization, and kinase activity.
2010-11
MDR1 function is sensitive to the phosphorylation state of myosin regulatory light chain.
2010-07-16
TRPC-mediated actin-myosin contraction is critical for BBB disruption following hypoxic stress.
2010-06
Cellular mechanisms of IL-17-induced blood-brain barrier disruption.
2010-04
Inhibition of myosin light chain kinase reduces brain edema formation after traumatic brain injury.
2010-02
Inhibition of myosin light chain phosphorylation decreases rat mesenteric lymphatic contractile activity.
2009-08
[Protective effect of myosin light-chain kinase inhibitor on acute lung injury].
2009-04
Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2.
2008-11-08
Myosin phosphorylation triggers actin polymerization in vascular smooth muscle.
2008-11
Dual role for myosin II in GLUT4-mediated glucose uptake in 3T3-L1 adipocytes.
2008-10-15
Extracellular matrix rigidity promotes invadopodia activity.
2008-09-09
In vivo phosphorylation of regulatory light chain of myosin II in sea urchin eggs and its role in controlling myosin localization and function during cytokinesis.
2008-02
Investigation into the signal transduction pathway via which heat stress impairs intestinal epithelial barrier function.
2007-11
The participation of the Na+-Ca2+ exchanger in primary cardiac myofibroblast migration, contraction, and proliferation.
2007-11
Myosin light chain kinase-independent inhibition by ML-9 of murine TRPC6 channels expressed in HEK293 cells.
2007-09
Inhibition of the myosin light chain kinase prevents hypoxia-induced blood-brain barrier disruption.
2007-07
Phospholipase C and myosin light chain kinase inhibition define a common step in actin regulation during cytokinesis.
2007-05-17
Calcium absorption by Cav1.3 induces terminal web myosin II phosphorylation and apical GLUT2 insertion in rat intestine.
2007-04-15
Organized migration of epithelial cells requires control of adhesion and protrusion through Rho kinase effectors.
2007-03
Myosin inhibitors block accumulation movement of chloroplasts in Arabidopsis thaliana leaf cells.
2007
Myosin light chain kinase is not a regulator of synaptic vesicle trafficking during repetitive exocytosis in cultured hippocampal neurons.
2006-11-08
Intracellular signal transduction for migration and actin remodeling in vascular smooth muscle cells after sphingosylphosphorylcholine stimulation.
2006-09
Thrombin-induced contraction in alveolar epithelial cells probed by traction microscopy.
2006-08
An MLCK-dependent window in late G1 controls S phase entry of proliferating rodent hepatocytes via ERK-p70S6K pathway.
2006-07
Myosin light chain kinase plays a role in the regulation of epithelial cell survival.
2006-06-01
Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells.
2006-05
Actin and non-muscle myosin II facilitate apical exocytosis of tear proteins in rabbit lacrimal acinar epithelial cells.
2005-10-15
Aluminium causes variable responses in actin filament cytoskeleton of the root tip cells of Triticum turgidum.
2005-10
Myosin 2 is a key Rho kinase target necessary for the local concentration of E-cadherin at cell-cell contacts.
2005-10
Effects of ML-7 and Y-27632 on carbachol- and endothelin-1-induced contraction of bovine trabecular meshwork.
2005-06
The inositol trisphosphate pathway mediates platelet-activating-factor-induced pulmonary oedema.
2005-05
LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK.
2005-05
Calcium transients regulate titin organization during myofibrillogenesis.
2005-03
Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity.
2005-02-01
Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium.
2005-01-01
Non-muscle myosin II and myosin light chain kinase are downstream targets for vasopressin signaling in the renal collecting duct.
2004-11-19
Differential regulation of human lung epithelial and endothelial barrier function by thrombin.
2004-11
Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
2004-08-01
Myosin-mediated cytoskeleton contraction and Rho GTPases regulate laminin-5 matrix assembly.
2004-02
The catalytic domain of xPAK1 is sufficient to induce myosin II dependent in vivo cell fragmentation independently of other apoptotic events.
2003-11-15
Regulation of renin secretion through reversible phosphorylation of myosin by myosin light chain kinase and protein phosphatase type 1.
1998-06
Adherent neutrophils activate endothelial myosin light chain kinase: role in transendothelial migration.
1998-05
An essential role of myosin light-chain kinase in the regulation of agonist- and fluid flow-stimulated Ca2+ influx in endothelial cells.
1998-03
Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds.
1997-12-24
ML-7 and W-7 facilitate thromboxane A2-mediated Ca2+ mobilization in rabbit platelets.
1996-03-07
Role of myosin phosphorylation and [Ca2+]i in myogenic reactivity and arteriolar tone.
1995-11
Naphthalenesulphonamides block neutrophil superoxide production by intact cells and in a cell-free system: is myosin light chain kinase responsible for these effects?
1995-10-01
Differentiation of human monoblastic leukemia U937 cells induced by inhibitors of myosin light chain kinase and prevention of differentiation by granulocyte-macrophage colony-stimulating factor.
1993-04-16
Diphosphorylation of platelet myosin ex vivo in the initial phase of activation by thrombin.
1992-07-22

Sample Use Guides

The rabbits were fed a high‑fat diet supplemented with 1 mg/kg/day ML7. Rats: 1 mg/kg ML-7 i.p.
Route of Administration: Other
1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine hydrochloride (ML-7), induced Nitroblue tetrazolium reducing activity, lysozyme activity and morphological maturation of human monoblastic U937, THP-1 and promyelocytic HL-60 cells, but not of erythroblastic K562 cells. 40 uM ML-7 induces activation of caspase-3 in adherent MCF-10A and MCF-10A Ras-transformed cells.
Name Type Language
ML-7
Common Name English
1H-1,4-DIAZEPINE, HEXAHYDRO-1-((5-IODO-1-NAPHTHALENYL)SULFONYL)-
Preferred Name English
NSC-734550
Code English
Code System Code Type Description
FDA UNII
E2C2LB77BF
Created by admin on Mon Mar 31 19:04:38 GMT 2025 , Edited by admin on Mon Mar 31 19:04:38 GMT 2025
PRIMARY
NSC
734550
Created by admin on Mon Mar 31 19:04:38 GMT 2025 , Edited by admin on Mon Mar 31 19:04:38 GMT 2025
PRIMARY
EPA CompTox
DTXSID60148917
Created by admin on Mon Mar 31 19:04:38 GMT 2025 , Edited by admin on Mon Mar 31 19:04:38 GMT 2025
PRIMARY
CAS
109376-83-2
Created by admin on Mon Mar 31 19:04:38 GMT 2025 , Edited by admin on Mon Mar 31 19:04:38 GMT 2025
PRIMARY
PUBCHEM
4216
Created by admin on Mon Mar 31 19:04:38 GMT 2025 , Edited by admin on Mon Mar 31 19:04:38 GMT 2025
PRIMARY